FTY720 Reduces Multiple Sclerosis Symptoms By 77% - Sustained Over 2 Years
Fri, 29 Sep 2006 09:00 PM EST
... The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide. [click link for full article] ...
Related Topics
- Multiple Sclerosis/ms
- Multiple Sclerosis
- Tuberous Sclerosis
- Myeloma, Multiple
- Multiple Myeloma
- Myeloma
- Lichen Sclerosis
- Multiple Chemical Sensitivity
- Amyotrophic Lateral Sclerosis
- Interferon Beta-1a Injection (Rebif
- Twins, Triplets, Multiple Births
- Interferon Beta-1a Injection (Avonex
- Multiple System Atrophy
- Recessive multiple epiphyseal dysplasia
- Naltrexone
- Hypothermia
- Death And Dying
- Aspartame
- Cerebral Atrophy
- Melanoma

Not Signed In -


